Conclusion This overview found no difference, either overall or within any subgroup, in mortality between CCT and MP. In terms of survival, these therapeutic options, as tested in the trials ...

The difference maps between 20 and 200 μM ATP for 8g (Fig. 4d) and 91A (Fig. 4h) antibody-bound CCT show almost no changes except in the region of subunit CCTβ.